This cohort study analyzed data from 49,237 women aged 40 to 79 diagnosed with breast cancer in Scotland (2010-2017) and Wales (2000-2016), with follow-up until 2020. It found that 5% of these patients used vaginal estrogen therapy (VET) post-diagnosis. After adjusting for confounders, the study found no evidence of increased
